Clinical Trial Update: Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin. [Phase 3]

View source ↗

Summary

Two Phase 3 studies evaluating verteporfin photodynamic therapy for multiple basal cell carcinomas of the skin were terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Gorlin Syndrome
• Nevoid Basal Cell Carcinoma Syndrome

Drugs mentioned

• Verteporfin (Visudyne) (verteporfin)

Snippet

Sponsor: QLT Inc. | Conditions: Basal Cell Carcinoma, Nevoid Basal Cell Carcinoma Syndrome | Phase 3 | Status: TERMINATED